doi: 10.3389/fendo.2023.1214334 Received 29 April 2023 Accepted 25 September 2023 Published 16 October 2023 Volume 14 - 2023 Edited by ke Sjholm, Gvle Hospital, Sweden Reviewed by Stanley Andrisse, Howard University, United States Ioannis Ilias, General-Maternity District Hospital Helena Venizelou, Greece Vivek P
Why CJC-1295 and Ipamorelin Are Almost Always Prescribed Together The pituitary has two distinct pathways for releasing growth hormone: the GHRH receptor and the ghrelin receptor
It was 52, which I was shaking, man
First characterised in receptor pharmacology studies published in the late 1990s (DOI 10.1046/j.1365-2265.1998.00629.x), ipamorelin was specifically designed to improve on the selectivity limitations of earlier GHRPs such as GHRP-2 and hexarelin, both of which produced meaningful elevations of cortisol and prolactin alongside GH stimulation
Frequently Asked Questions About Ozempic We understand you may have questions about this new medication
First principles: when stacking makes sense vs when its just noise Heres the simplest clinical lens I know: A stack can be reasonable when it meets all 4 criteria Different primary mechanisms (true complement, not redundancy) A clear problem statement (e.g., Im losing weight but also losing lean mass vs I want to feel optimized) Human evidence exists for at least one component and the combined physiology isnt contradictory You can monitor outcomes and safety objectively (labs, body composition, symptoms, performance, vitals) A stack is usually unjustified when it has any of these patterns Redundant signaling (two compounds tugging the same rope) Unmonitorable goals (recovery, vitality, anti-aging without measurable endpoints) Axis overstimulation (especially GH/IGF-1 signaling) Quality/sterility uncertainty (common with online research vials) No exit plan (no defined stop criteria or reassessment window) The 4 major peptide lanes youll see in stacking culture Most stacks are built from some combination of these buckets: Incretin/metabolic lane (GLP-1/GIP-based pharmacologytypically FDA-approved drugs rather than peptides in the wellness sense) GH/IGF-1 lane (GHRH analogs and ghrelin receptor agonists/secretagogues) Lipolytic fragments/modulators (often marketed for fat loss
